These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2659528)

  • 1. Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection.
    Harmon RC; Rutherford RL; Wu HM; Collins MS
    Infect Immun; 1989 Jul; 57(7):1936-41. PubMed ID: 2659528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.
    Moayeri N; Collins CM; O'Hanley P
    Infect Immun; 1991 Oct; 59(10):3778-86. PubMed ID: 1894376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal immunization with attenuated Salmonella Typhimurium expressing an MrpA-TetC fusion protein significantly reduces Proteus mirabilis colonization in the mouse urinary tract.
    Scavone P; Umpiérrez A; Maskell DJ; Zunino P
    J Med Microbiol; 2011 Jul; 60(Pt 7):899-904. PubMed ID: 21415205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.
    Scavone P; Miyoshi A; Rial A; Chabalgoity A; Langella P; Azevedo V; Zunino P
    Microbes Infect; 2007 Jun; 9(7):821-8. PubMed ID: 17540603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulin response and protection from homologous challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection.
    Johnson DE; Bahrani FK; Lockatell CV; Drachenberg CB; Hebel JR; Belas R; Warren JW; Mobley HL
    Infect Immun; 1999 Dec; 67(12):6683-7. PubMed ID: 10569791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against experimental Proteus mirabilis pyelonephritis in rats and significance of immunity.
    Larsson P; Kaijser B; Olling S; Akerlund AS
    Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):215-20. PubMed ID: 31056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
    Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
    FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
    Zaĭtsev EV; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal vaccination of mice with recombinant Proteus mirabilis structural fimbrial proteins.
    Scavone P; Sosa V; Pellegrino R; Galvalisi U; Zunino P
    Microbes Infect; 2004 Jul; 6(9):853-60. PubMed ID: 15374007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection of mice provided by active and passive immunization against experimental infections with virulent Proteus rettgeri and Providencia bacteria.
    Penner JL; Whiteley GR
    Infect Immun; 1978 May; 20(2):347-51. PubMed ID: 669801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
    Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P
    Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.
    Barbour AG; Bundoc V
    Infect Immun; 2001 Feb; 69(2):1009-15. PubMed ID: 11159997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination to Protect Against Proteus mirabilis Challenge Utilizing the Ascending Model of Urinary Tract Infection.
    Smith SN; Himpsl SD; Mobley HLT
    Methods Mol Biol; 2019; 2021():201-215. PubMed ID: 31309507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls.
    Senior BW; Anderson GA; Morley KD; Kerr MA
    J Infect; 1999 Mar; 38(2):99-106. PubMed ID: 10342649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the administration of cholera toxin as a mucosal adjuvant on the immune and protective response induced by Proteus mirabilis MrpA fimbrial protein in the urinary tract.
    Scavone P; Rial A; Umpierrez A; Chabalgoity A; Zunino P
    Microbiol Immunol; 2009 Apr; 53(4):233-40. PubMed ID: 19714860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Taishan Pinus massoniana pollen polysaccharide on the subunit vaccine of Proteus mirabilis in birds.
    Cui G; Zhong S; Yang S; Zuo X; Liang M; Sun J; Liu J; Zhu R
    Int J Biol Macromol; 2013 May; 56():94-8. PubMed ID: 23403027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Gram-negative infection by 'super-active' antigen.
    Roe EA
    Immunology; 1976 Nov; 31(5):707-15. PubMed ID: 825449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity induced by the vaccination of recombinant Proteus mirabilis OmpA expressed in Pichia pastoris.
    Zhang Y; Yang S; Dai X; Liu L; Jiang X; Shao M; Chi S; Wang C; Yu C; Wei K; Zhu R
    Protein Expr Purif; 2015 Jan; 105():33-8. PubMed ID: 25317910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccination against Porteus mirabilis.
    Jones RJ
    Br J Exp Pathol; 1976 Aug; 57(4):395-9. PubMed ID: 822863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination immunogenic property of truncated MrpH.FliC as a vaccine candidate against urinary tract infections caused by Proteus mirabilis.
    Bameri Z; Asadi Karam MR; Habibi M; Ehsani P; Bouzari S
    Microb Pathog; 2018 Jan; 114():99-106. PubMed ID: 29138084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.